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ABSTRACT 
 
Background: Early diagnosis and proper management of neonatal septicemia can bring down the 
morbidity and mortality substantially.4 Hence the aim of this study was to study the bacteriological 
profile of neonatal septicemia cases and their antibiogram for planning strategy for the management 
of these cases. 
Methodology: A retrospective study of bacterial isolates from cases of neonatal septicemia was 
undertaken over a period of 13 months from January 2006 to February 2007 at B.J.Medical College, 
Civil Hospital, Ahmedabad, Gujarat. 
Result: Blood culture was positive in 55.6% of cases. Gram negative septicemia was encountered in 
63% and it was predominant septicemia compared to gram positive septicemia. Klebsiella species 
(59.10%) and Escherichia coli (31.99%) were the predominant pathogens followed by Pseudomonas, 
Acinetobacter and Citrobacter species. The most effective antimicrobials against Klebsiella species and 
Escherichia coli were Carbapenems followed by Piperacillin + Tazobactam, 2nd generation Quinolones 
and Amoxicillin + Clavulonic acid. Where as in case of Pseudomonas 2nd generation Quinolones were 
most effective followed by Carbapenems, Aminoglycosides, Piperacillin + Tazobactam, Ceftazidime 
and Aztreonam. Out of 187 gram positive isolates, 171 (91.4%) were coagulase negative staphylococci, 
8 (4.3%) were staphylococcus aureus, and 8 (4.3%) were streptococci. Gram positive isolates were 
more sensitive to Vancomycin followed by Linezolid, Clindamycin and higher Quinolones.  
Conclusion: Neonatal septicemia is a life-threatening emergency, and rapid treatment with antibiotics 
is essential for favourable outcome. For effective management of neonatal septicemia cases, strategy 
of antibiotic usage in the hospital must be reviewed  
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INTRODUCTION 
Septicemia in neonates refers to the presence of 
microbes or their toxins in blood.1 It is 
documented by positive blood culture in the first 
four weeks of life and is one of the leading 
causes of neonatal mortality in India.2 Prior to 
the antibiotic era, the mortality from septicemia 
was 90%. But with presently available 
antimicrobial agents, it may be treated 
successfully and mortality from septicemia in 
neonates has declined to 24.58%.3, 4 
However, with presently available antimicrobial 
agents, neonatal septicemia may be treated 
successfully. Early diagnosis and proper 
management of neonatal septicemia can bring 
down the morbidity and mortality 
substantially.4 Hence the aim of this study was 
to study the bacteriological profile of neonatal 
septicemia cases and their antibiogram for 
planning strategy for the management of these 
cases. 
 
MATERIALS AND METHODS 
The study was conducted in the Microbiology 
Department at B.J.Medical College, Ahmedabad, 
India. This is a tertiary care centre with more 
than 2200 bedded hospital. This is a 
retrospective study.   
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Table 1: Antibiotics used with their 
concentrations and codes 
Antibiotic Code  Concentratio
n 
Gram negative bacilli     
Ampicillin+Sulbactam AMC  20μg 
Cefuroxime CXA  30 μg 
Ceftriaxone CRO  30 μg 
Cefoperazone+ 
Sulbactam 
CSL  105 μg 
Ciprofloxacin CIP  5 μg 
Levofloxacin LVX  5 μg 
Meropenem ME
M 
10 μg 
Gentamycin GEM  10 μg 
Amikacin AM
K 
30 μg 
Tetracycline TCY  30 μg 
Chloramphenicol CHL  30 μg 
Cotrimoxazole SXT  25 μg 
Piperacillin+Tazobacta
m 
TZP  110 μg 
Cefotaxime CTX  30 μg 
Ceftazidime CAZ  30 μg 
Aztreonam ATM  30 μg 
Gram positive species    
Azithromycin AZM  15 μg  
Linezolid LNZ  30 μg  
Vancomycin VAN  30 μg  
Oxacillin CLO  1μg  
Ciprofloxacin CIP  5 μg 
Levofloxacin LVX  5 μg 
Clindamycin CLI  2 μg 
Gentamycin GEM  10 μg 
Penicillin G  PEN  10 U 
Tetracycline TCY  30 μg 
Chloramphenicol CHL  30 μg 
Cotrimoxazole SXT  25 μg 
 
All data is collected from the samples received 
in our department. (So, Ethical committee 
permission is not required). Blood from 900 
neonates admitted in NICU with clinical 
suspicion of septicemia was collected for culture 
and sensitivity, during the period of January 
2006 to February 2007.  
The processing of blood samples for culture and 
isolate identification was done by standard 
methods.5  The antibiotic susceptibility was 
determined by the stokes disk diffusion method 
as per NCCLS recommendations.6  
RESULT AND DISCUSSION 
Table 1 shows the names and concentrations (in 
μg) of various antibiotics used. The plates were 
incubated at 37°C and reading was taken after 
overnight incubation. 
Table 2 shows rates of isolates in percentage (%). 
 
Table 2: Percentage of various isolates from 500 
positive samples 
Organism No.  of 
isolates  
% 
Klebsiella species  185  37 % 
E.coli  100 20  % 
Pseudomonas spp.  20  4 % 
Acinetobacter spp.  6  1.2 % 
Citrobacter spp. 2  0.4  % 
Coagulase negative 
staphylococci 
171 34.2  % 
Staphylococcus aureus  8  1.6% 
Streptococci 8  1.6% 
Total  500 100% 
 
Table 3a shows Antibiotics sensitivity results of 
the gram negative isolates in percentage (%). 
In this study blood culture positivity rate in 
neonatal septicemia cases was 56.67% whereas 
in 43.33% of cases there was no growth. A study 
done by Sharma et al also reported positivity 
rate 56 % which was well correlated with our 
study. 7  Gram-negative isolates constituted 
major group (62.48 %), than Gram positive 
isolates (37.33%), which is comparable with the 
study of Nalini et al (58.5 % and 48.5% 
respectively).2  
Table 3b shows Antibiotic sensitivity of Gram 
positive isolates in percentage (%). 
Among all the isolates Klebsiella species has been 
found to be predominant pathogen (59.10%) 
followed by Escherichia coli (31.94%), 
Pseudomonas  (6.4%),  Acinetobacter (1.9%) and 
Citrobacter species (0.63%). This predominance of 
Klebsiella species was correlated with the study 
done by Mathur M et al.4 In case of gram positive 
isolates coagulase negative staphylococci were 
the most common (91.4%), comparable with the 
study of Fleer A et a.l(more than 90%). 8  
Empirical initial treatment of neonatal sepsis 
consists of Ampicillin and Aminoglycosides.9 
But results of antibiotic sensitivity of our study 
revealed that majority of Gram negative isolates 
(Klebsiella species and Escherichia coli) were 
sensitive to MEM (95 % and 97 %), TZP (88 % 
and 91 %), LVX (84 % and 81 %) and AMC (58%  
 
pISSN: 0976 3325 eISSN: 2229 6816 
National Journal of Community Medicine Vol 3 Issue 2 April-June 2012  Page 240 
 
 
and 49%) respectively. Where as sensitivity 
pattern of Pseudomonas  species  was different, 
Pseudomonas species was sensitive to LVX ( 70% 
), MEM ( 65% ), AMK ( 60% ), TZP and CAZ ( 55 
% each ), suggesting that in comparison to other 
Gram negative bacilli Pseudomonas species was 
more sensitive to higher Quinolones, 
Carbapenems, Aminoglycosides, among 3rd 
generation Cephalosporins to ceftazidime, β 
lactam + β lactamase inhibitor ( 
Piperacillin+Tazobactam) and Monobactam. In 
this study the rate of isolation of Acinetobacter 
and Citrobacter species was very low (2.53%). In 
addition to TZP, LVX and MEM, they were also 
sensitive to Ciprofloxacin.  
 
Table 3a: Antibiotic sensitivity of Gram negative isolates in percentage (%) 
Organism S/I  Drugs 
AMC CXA CRO  CSL  MEM  GEM  AMK  CIP LVX TCY  CHL  SXT 
Klebsiella spp.   S  58  6  9  88 95 10 38 31 84 14 46 15 
I  11  0.5  0.5  3.2  0 4 5 9 8 8 2 2 
E.coli  S  49  7  12 91 91 29 49 24 81 15 33 39 
I  19  3 2 0 0 1 3  12  9 5 6 1 
Acinetobacter spp.  S  50 0 17  83  67  33 0 66  83 0 33 0 
I  17 17 33  0  17 17 50  0  0  17  0  0 
Citrobacter spp.  S  0  0  50  100 100  50  50  100 100  0  50  50 
I  50  0 0 0 0 0 0 0 0 0 0 0 
 S/I  Drugs 
CTX CAZ ATM  TZP  MEM  GEM  AMK  CIP LVX TCY  CHL  SXT 
Pseudo-monas 
spp. 
S  35 25 55 55 65 30 60 35 70 15  5  10 
I  0 0 0  10  5 5 5 5 0 5 0 5 
S = Sensitive, I = Intermediate  
 
Table 3b: Antibiotic sensitivity of Gram positive isolates in percentage (%) 
Organism S/I  Drugs 
PEN CLO GEN  CIP  LVX  TCY  CHL  SXT  AZM  CLI VAN LNZ 
Staphylococci coagulase -
ve 
S  30 45 46 54 79 40 78 22 40 76  100  97 
I  2 2 7 4 4 7 3 1 6 0 0 0 
Staphylococcus aureus  S  25 50 63 50 75  37.5  63 25 38 63  100  87.5 
I  12.5 0 12.5  25 12.5  12.5  12.5  0 25 0  0  0 
Streptococci  S  63 50 50 63 63 63  87.5  63 63  100  100  100 
I 0  0  0  12.5  0 12.5  0 0 0 0 0 0 
S = Sensitive, I = Intermediate  
 
Among gram positive isolates the coagulase 
negative staphylococci were most sensitive to 
vancomycin (100%) followed by linezolid (97%), 
levofloxacin (79%) chloamphenicol(78%), and 
clindamycin (76%). Other gram positive isolates 
(streptococci and staphylococcus aureus) were 
also sensitive to above mentioned drugs.  
 
CONCLUSION 
Neonatal septicemia is the single most important 
cause of neonatal deaths in the community 
a c c o u n t i n g  f o r  o v e r  h a l f  o f  t h e m .  I t  i s  a  l i f e -
threatening emergency, and rapid treatment 
with antibiotics is essential for favorable 
outcome. For effective management of neonatal 
septicemia cases, the study of bacteriological 
profile with their antibiotic sensitivity pattern 
plays a significant role. In view of the above 
facts the strategy of antibiotic usage in the 
h o s p i t a l  m u s t  b e  r e v i e w e d  a n d  w e  a r e  o f  t h e  
opinion that health care practitioners and policy 
makers could address this problem by 
implementing a more rational and appropriate 
use of antibiotics.  
 
REFERENCES 
1.  Lesser CF, Miller SI. Septicemia. In: Braunwald E, 
Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson 
JL, eds. Harrison's Principles of Internal Medicine. 15th 
ed. McGraw-Hill Company, 2001; vol.1: 970-974.  
 
pISSN: 0976 3325 eISSN: 2229 6816 
National Journal of Community Medicine Vol 3 Issue 2 April-June 2012  Page 241 
 
 
2.  Agnihotri N, Kaistha N, and Gupta V. Antimicrobial 
Susceptibility of Isolates from Neonatal Septicemia. Jpn. 
J. Infect. Dis. 2004; 57: 273-275.    
3.  K a u s h i k  S L ,  P a r m a r  V R ,  G r o v e r  N ,  G r o v e r  P S  a n d  
Kaushik R. Neonatal sepsis in hospital born babies. J. 
Commun. Dis. 1998; 30: 147-152.  
4.  M a t h u r  M ,  S h a h  H ,  D i x i t  K ,  K h a m b a d k o n e  S ,  
Chakrapani A, Irani S. Bacteriological profile of 
neonatal septicemia cases. J Postgrad Med. 1994, 40: 18-
20.  
5.  Collee JG, Fraser AG, Marmion BP, Simmons A. 
Culture of Bacteria. In: Mackie McCartney Practical 
Medical Microbiology, 14th ed, (Churchill Livingstone, 
London), 1996: 113-129. 
6.  National Committee for Clinical Laboratory Standards: 
Performance standards for antimicrobiol susceptibility 
testing. 8th Information Supplement M2A7. Vol 20, No 
1-2, National Committee for Clinical Laboratory 
Standards, Villanova, Pa. 
7.  Sharma PP, Halder D, Dutta AK. Bacteriological profile 
of neonatal septicemia. Indian Pediatr. 1987, 24: 1011-
1017. 
8.  In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson 
Text Book of Pediatrics. 16th ed. W.B.Saunders 
Company Publisher ,2000; vol.1: 544-552. 
9.  Fleer A, Verhoef J, Pascual A. The pathogenic role of 
coagulase negative staphylococci. Am J Med 1986. Jan 
30, 80 (6B):161-5. 
 
Correspondence:  
Dr. Sima Bhatt 
6/A, Vrundavan Colony, 
B/h Ghever Complex,  
Shahibaug, Ahmedabad – 4.  
E mail: drsima69@yahoo.com,  
Phone: 9898462416 
 